RESUMEN
BACKGROUND: Breast augmentation is one of the most common aesthetic procedures worldwide. Most studies focused on evaluating the outcome with validated patient-reported outcome measures (PROMs) and factors that may influence them. However, the influence of care delivery, which can be measured with patient-reported experience measures (PREMs), is scarce in breast augmentation patients. OBJECTIVES: This study aimed to evaluate the associations between PREMs and PROMs in patients who underwent breast augmentation. METHODS: A multicenter cohort study was conducted in breast augmentation patients. Patients completed PREMs, including aspects such as communication between physician and patient, expectation management, welcome, and hygiene and the BREAST-Q PROM Satisfaction with Breasts, Psychosocial-, Physical- and Sexual well-being, preoperatively and six-months postoperatively. Regression analyses were used to investigate the associations between PREMs and PROMs. RESULTS: Overall, 329 patients were included between 2018-2022. Univariate regression analysis showed a positive association between PREMs and PROMs scales. The aspects of the feeling of being heard (B=-38.39 and B=-18.90), the opportunity to ask questions (B=-9.21) and trust in their physician (B=-39.08) had the highest association with the change in the four BREAST-Q scales. The multivariable regression analysis showed that the variance in PROMs related to changes in PREMs (19%) was hardly influenced by patient characteristics (1%). CONCLUSIONS: Patient outcomes are more positive after breast augmentation when patients feel they are being heard, have the opportunity to ask questions and have trust in their physician. Future studies should be targeted at optimizing patient-reported experience to investigate whether this would improve patient-reported outcomes.
RESUMEN
Background: Upper blepharoplasty is the most popular facial cosmetic surgery. Although there are a variety of reasons to undergo this procedure, all patients expect an optimal cosmetic result. However, little is known about the factors that influence satisfaction with treatment outcome. Objectives: We assessed to what extent patient characteristics, clinician-rated and postsurgical outcome measures, and patient-reported satisfaction with facial appearance and quality-of-life are associated with patient-reported satisfaction with treatment outcome after a primary upper blepharoplasty. Methods: This study was performed in 583 patients with an upper blepharoplasty between 2016 and 2021. The primary outcome was satisfaction with treatment outcome 6 months postoperatively using the FACE-Q. Determinants were baseline patient characteristics (demographics), preoperative and postoperative clinician-rated and surgical outcome measures, and preoperative and postoperative FACE-Q appearance and quality-of-life scales. Hierarchical linear regression analysis was used to determine how much of the variance in satisfaction with outcome could be explained by these groups of determinants. Results: A total of 63% of the variance could be explained by the five groups of determinants of which 8% was explained by the baseline patient characteristics and clinician-rated and patient-reported outcomes together, another 8% by the postoperative clinician-rated outcomes, and the remaining 47% by the postoperative patient-reported outcomes. Conclusions: Patient characteristics, clinician-rated outcome measures, and baseline FACE-Q appearance and quality-of-life scores were of limited value in explaining satisfaction with treatment outcome. However, the postoperative FACE-Q appearance scale and the decision to undergo a blepharoplasty were strongly associated with satisfaction with treatment outcome.
RESUMEN
BACKGROUND: To evaluate the success of a breast augmentation, it is essential to measure outcomes from the patient perspective since a successful aesthetic result is especially determined by the patient. This study aimed to evaluate patient-reported satisfaction with their breasts, psychosocial, physical, and sexual well-being in patients undergoing breast augmentation using validated questionnaires. METHODS: This is a multicenter cohort study based on ongoing routinely-collected data. Patient-reported satisfaction and health-related quality of life were assessed with the BREAST-Q Augmentation Module at intake and six months postoperatively. RESULTS: A total of 1405 patients were included. Large changes in BREAST-Q scores (range, 0-100) between intake and six months postoperatively were seen: satisfaction with their breasts (mean, effect size: +57, 3.8), psychosocial well-being (+38, 2.1), physical well-being (-14, -1.2), and sexual well-being (+44, 2.4). Moreover, improvements in all four scales were not dependent on their intake scores and all postoperative scores reached similar levels. A decreased physical well-being of the chest was measured post-surgery. The satisfaction with the breasts scale correlated moderately to strongly with the psychosocial and sexual well-being scale 6 months post-surgery. Subgroup analysis based on patient characteristics found no differences in outcomes, except for BMI. CONCLUSION: Significant improvement in patient-reported satisfaction with their breasts, psychosocial, and sexual well-being can be seen six months after breast augmentation despite a declined physical well-being after treatment. Postoperative satisfaction levels do not depend on preoperative scores. These insights can contribute to improve preoperative communication between surgeon and patient regarding the expected outcomes.
RESUMEN
BACKGROUND: To determine the success of an upper blepharoplasty, a popular cosmetic procedure, it is essential to measure outcomes from the patient perspective because these often outweigh objective outcomes. OBJECTIVES: This study aimed to assess patient-reported satisfaction with facial appearance, psychological well-being, and aging appraisal after upper blepharoplasty with validated questionnaires. METHODS: This prospective cohort study included upper blepharoplasty patients from 8 outpatient clinics. Patient-reported satisfaction was assessed with the FACE-Q at intake, and 6 and 12 months postoperatively. RESULTS: In total, 2134 patients were included. High satisfaction with outcome and decision to undergo treatment were measured 6 months postoperatively. Large improvements in FACE-Q scores (range, 0-100) between intake and 6 months postoperatively were seen for satisfaction with appearance (mean, effect size: eyes +48, 2.6; upper eyelids +48, 3.1; facial appearance overall +26, 1.4), psychological well-being (+11, 0.56), and aging appraisal (+22, 1.0). Patients reported they appeared a mean [standard deviation] 3.3 [5.2] years younger postblepharoplasty. No clinically relevant changes were seen between 6 and 12 months. Additionally, improvements in appearance were not dependent on their intake scores, whereas improvements in psychological well-being and aging appraisal were smaller in patients with higher intake scores. Satisfaction with treatment outcome was strongly correlated with appearance satisfaction but not with aging appraisal. CONCLUSIONS: Significant improvements in patient satisfaction regarding appearance, psychological well-being, and aging appraisal can be seen 6 months after blepharoplasty, and outcomes remain stable up to 12 months postoperatively. These data may be used to inform patients and clinicians and improve the overall quality of care.